KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Cash & Current Investments (2009 - 2026)

Abbott Laboratories recorded quarterly Cash & Current Investments of $7.3 billion in Q1 2026, down 18.39% quarter-over-quarter from $8.9 billion in Q4 2025, and up 6.59% year-over-year from $6.8 billion in Q1 2025.

Abbott Laboratories' Cash & Current Investments history runs 18 years deep, the most recent figure standing at $7.3 billion for Q1 2026.

  • In Q1 2026, Cash & Current Investments rose 6.59% year-over-year to $7.3 billion; the TTM figure through Mar 2026 stood at $7.3 billion (up 6.59% YoY), while the FY2025 annual figure was $8.9 billion, up 12.2% from the prior year.
  • Cash & Current Investments came in at $7.3 billion for Q1 2026 at Abbott Laboratories, down from $8.9 billion in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $10.2 billion in Q4 2022 to a low of $6.7 billion in Q1 2024.
  • A 5-year average of $8.1 billion and a median of $7.8 billion in 2024 frame the typical range for Cash & Current Investments.
  • Across the five-year window, Cash & Current Investments advanced 16.84% in 2023 and sank 30.22% in 2024, its largest moves.
  • Abbott Laboratories' Cash & Current Investments stood at $10.2 billion in 2022, then fell by 28.43% to $7.3 billion in 2023, then advanced by 9.45% to $8.0 billion in 2024, then rose by 12.2% to $8.9 billion in 2025, then fell by 18.39% to $7.3 billion in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $7.3 billion, $8.9 billion, and $7.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 7.30 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 2.88 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 8.38 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.45 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 3.67 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.12 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1.12 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 2.29 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 439.60 Mn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 424.20 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 7.30 Bn
Dec 31, 2025 8.94 Bn
Sep 30, 2025 7.73 Bn
Jun 30, 2025 7.28 Bn
Mar 31, 2025 6.84 Bn
Dec 31, 2024 7.97 Bn
Sep 30, 2024 7.79 Bn
Jun 30, 2024 7.22 Bn
Mar 31, 2024 6.65 Bn
Dec 31, 2023 7.28 Bn
Sep 30, 2023 7.05 Bn
Jun 30, 2023 8.16 Bn
Mar 31, 2023 9.53 Bn
Dec 31, 2022 10.17 Bn
Sep 30, 2022 9.91 Bn
Jun 30, 2022 9.29 Bn
Mar 31, 2022 8.16 Bn
Dec 31, 2021 10.25 Bn
Sep 30, 2021 9.69 Bn
Jun 30, 2021 8.94 Bn
Mar 31, 2021 8.37 Bn
Dec 31, 2020 7.15 Bn
Sep 30, 2020 4.73 Bn
Jun 30, 2020 5.04 Bn
Mar 31, 2020 3.67 Bn
Dec 31, 2019 4.14 Bn
Sep 30, 2019 4.34 Bn
Jun 30, 2019 3.38 Bn
Mar 31, 2019 3.26 Bn
Dec 31, 2018 5.23 Bn
Sep 30, 2018 7.55 Bn
Jun 30, 2018 3.26 Bn
Mar 31, 2018 4.04 Bn
Dec 31, 2017 10.70 Bn
Sep 30, 2017 11.20 Bn
Jun 30, 2017 9.84 Bn
Mar 31, 2017 8.86 Bn
Dec 31, 2016 21.88 Bn
Sep 30, 2016 4.51 Bn
Jun 30, 2016 4.44 Bn
Mar 31, 2016 3.96 Bn
Dec 31, 2015 6.13 Bn
Sep 30, 2015 6.14 Bn
Jun 30, 2015 11.18 Bn
Mar 31, 2015 9.85 Bn
Dec 31, 2014 4.46 Bn
Sep 30, 2014 4.88 Bn
Jun 30, 2014 7.06 Bn
Mar 31, 2014 7.05 Bn
Dec 31, 2013 8.10 Bn
Sep 30, 2013 8.61 Bn
Jun 30, 2013 9.39 Bn
Mar 31, 2013 8.52 Bn
Dec 31, 2012 15.17 Bn
Sep 30, 2012 11.50 Bn
Jun 30, 2012 11.00 Bn
Mar 31, 2012 9.53 Bn
Dec 31, 2011 8.10 Bn
Sep 30, 2011 7.98 Bn
Jun 30, 2011 8.89 Bn
Mar 31, 2011 4.61 Bn
Dec 31, 2010 5.52 Bn
Sep 30, 2010 3.85 Bn
Jun 30, 2010 4.37 Bn
Mar 31, 2010 1.87 Bn
Dec 31, 2009 9.93 Bn
Sep 30, 2009 8.70 Bn
Jun 30, 2009 6.89 Bn